Welcome to the July edition of BioMatrix Abstract!

Welcome to the July edition of BioMatrix Abstract!

BioMatrix Abstract informs readers of our leading efforts in the specialty pharmacy space while providing updates on relevant legislative efforts, research initiatives, and current events in healthcare.


Lambert-Eaton Myasthenic Syndrome (LEMS)

No alt text provided for this image

Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare, autoimmune, neurological disorder in which the body's immune system attacks its own tissues. Here's some signs and symptoms to look out for as well as treatment options for LEMS. Read more.


Vyvgart? (efgartigimod alfa-fcab) is now available at BioMatrix Specialty Pharmacy!?

No alt text provided for this image

BioMatrix Specialty Pharmacy offers a full line of IG and ancillary medications, including Vyvgart. Our clinical team develops personalized care plans for every patient, including coordination of in-home nursing services, when necessary. We’re changing lives and improving health, one patient at a time.?Submit a Referral Today.



Putting Your Mask on First

No alt text provided for this image

When you’re a caretaker for a loved one with a chronic condition—whether it be for a child or adult, you may have experienced frustration, anxiety, and difficulties with your own health. This article gives some signs to look out for as well as tips to help mitigate caregiver burnout. Read more.


BioMatrix on the Move!

No alt text provided for this image

Upcoming Events

Catch up with BioMatrix at these upcoming events. We can't wait to see you!

  • 9/8 to 9/10:?Familia de Sangre (for Bleeding Disorders) in Anaheim, CA
  • 9/18 to 9/21:?NASP Annual Meeting & Expo in Grapevine, TX?


BioMatrix Was Proud to Attend and Support These Meetings

Thanks to all who visited the BioMatrix booth!

  • Charlotte Prohaska and Sue Clay from our Transplant team attended the Congress of the Intestinal Rehabilitation and Transplant Association (CIRTA)?on June 30th in Chicago, IL.


No alt text provided for this image

BioMatrix in Focus: Neuromuscular Conditions

BioMatrix has extensive experience with neuromuscular conditions.?

As a national provider of IG, BioMatrix has broad access to brands and inventory supply. We purchase IG directly from manufacturers or manufacturers’ approved distributors, ensuring distribution channel integrity, proper handling, and quality control. We understand the important role IG plays in treating neuromuscular conditions.?

Our national network of highly qualified infusion nurses specializes in the administration of IG. Our nursing team coordinates the best site of care for scheduled infusions—whether in the patient’s home or physician’s office. Providing site-of-care options offers convenience for patients and cost-savings to insurance providers.

>>?Learn more about some of the neuromuscular conditions we help manage treatment for.

>>?Submit a Referral Today


No alt text provided for this image

Medicaid?

The Biden Administration has urged states to slow down their Medicaid disenrollment as patients and families rapidly lose coverage. Some states have already disenrolled as many as half of their Medicaid recipients, but the Centers for Medicare and Medicaid Services (CMS) expressed concern since the primary reason cited for disenrollment was “procedural” which can be a violation such as an unreturned form or phone call. Federal officials are encouraging states to delay procedural terminations. Of the almost 1 million who have now lost Medicaid coverage, 1 in 5 were due to procedural reasons.?

>> Biden Urges Medicaid Disenrollment to Slow Down

>> More Than 1 Million Dropped from Medicaid?


340B

PhRMA, the lobby group for pharmaceutical manufactures, is targeting federal grantee 340B programs like Ryan White Clinics and HTCs. A new study claims federal programs are reimbursed 3.7 times more than they pay for 340B drugs, earning $8-12 billion in 2020, but the Berkeley Research Group (funded by Gilead) could not find what grantees are doing with that money. PhRMA has raised concerns about contract pharmacies causing diversion and duplicate discounts within DSH 340B programs, and, with this report, claims grantees exhibit the same problems. Between 2017 and 2020, contract pharmacies at federal grantee 340B programs increased 252% and make up over half (55%) of all contract pharmacy arrangements.

>> Report Raises Concerns Over Federal Grantee 340B Programs


Prior Authorization

Congressional lawmakers are urging the Centers for Medicare and Medicaid Services (CMS) to change the prior authorization (PA) process which insurers use to approve certain medicines and procedures. Lawmakers seek a 24-hour limit for PA decisions regarding urgent care; a streamlined electronic approval process for routine services; and a transparency of metrics used for PA decisions.

>> Lawmakers Ask for Changes to Prior Authorization Process


>>?Click here to get BioMatrix Abstract sent to your email once monthly!


BioMatrix Specialty Pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions.

>>?Visit our website!















Susan Moore

Semi-retired at Home Office

1 年

BioMatrix gives the best information - easy to understand and interesting.

要查看或添加评论,请登录

BioMatrix Specialty Infusion Pharmacy的更多文章

社区洞察

其他会员也浏览了